{
    "SPADE_UN_11990": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11990",
            "Peptide Name": "KL0A10 (De novo synthesis)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "AAKAAAKAAAKAA",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.26385363] Gram-positive bacteria :Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Streptococcus faecalis ATCC 29212(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC>128 μM);Gram-negative bacteria :Escherichia coli ATCC25922(MIC>128 μM), Escherichia coli K88(MIC>128 μM), Escherichia coli CVCC 1515(MIC>128 μM), Escherichia coli UB1005(MIC>128 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM)",
            "Hemolytic Activity": "[Ref.26385363] MHC5>256 μM against human red blood cells",
            "Cytotoxicity": "[Ref.26385363] The cell viability of HEK293 cells induced by KL0A10 is 103.9%, 110%, 110.6%, 107.8%, 110.3%, 110.1%, 107.2% and 106.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control M",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C48H88N16O14",
            "Mass": 1113.31,
            "PI": 10.3,
            "Net Charge": 3,
            "Hydrophobicity": 0.48,
            "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Uncertain antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.",
            "Literature": [
                {
                    "Title": "Rational design of mirror-like peptides with alanine regulation.",
                    "Pubmed ID": "26385363",
                    "Reference": "Amino Acids. 2016 Feb;48(2)403-17. doi 10.1007/s00726-015-2094-y.",
                    "Author": "Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26385363"
                },
                {
                    "Title": "Rational design of mirror-like peptides with alanine regulation",
                    "Pubmed ID": "",
                    "Author": "Li W, Tan T, Xu W, Xu L, Dong n, Ma D, Shan A"
                }
            ],
            "Frequent Amino Acids": "AK",
            "Absent Amino Acids": "CDEFGHILMNOPQRSTUVWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 13,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06020",
                    "Similarity": 1.0,
                    "Sequence": "KAAAKAAKAA"
                },
                {
                    "SPADE_ID": "SPADE_UN_15903",
                    "Similarity": 1.0,
                    "Sequence": "KAAK"
                },
                {
                    "SPADE_ID": "SPADE_UN_23431",
                    "Similarity": 1.0,
                    "Sequence": "AAAK"
                }
            ]
        }
    }
}